DK1297110T3 - Attenueret bovin respiratorisk syncytialvirus - Google Patents

Attenueret bovin respiratorisk syncytialvirus

Info

Publication number
DK1297110T3
DK1297110T3 DK01938170T DK01938170T DK1297110T3 DK 1297110 T3 DK1297110 T3 DK 1297110T3 DK 01938170 T DK01938170 T DK 01938170T DK 01938170 T DK01938170 T DK 01938170T DK 1297110 T3 DK1297110 T3 DK 1297110T3
Authority
DK
Denmark
Prior art keywords
respiratory syncytial
bovine respiratory
syncytial virus
attenuated bovine
viruses
Prior art date
Application number
DK01938170T
Other languages
English (en)
Inventor
Ulrike Schmidt
Ursula J Buchholz
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of DK1297110T3 publication Critical patent/DK1297110T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
DK01938170T 2000-06-23 2001-05-02 Attenueret bovin respiratorisk syncytialvirus DK1297110T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202183 2000-06-23
PCT/EP2001/005085 WO2002002752A1 (en) 2000-06-23 2001-05-02 Attenuated bovine respiratory syncytial virus

Publications (1)

Publication Number Publication Date
DK1297110T3 true DK1297110T3 (da) 2009-11-16

Family

ID=8171676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01938170T DK1297110T3 (da) 2000-06-23 2001-05-02 Attenueret bovin respiratorisk syncytialvirus

Country Status (9)

Country Link
US (2) US6921535B2 (da)
EP (1) EP1297110B1 (da)
AT (1) ATE437223T1 (da)
AU (1) AU2001263896A1 (da)
CA (1) CA2412075C (da)
DE (1) DE60139319D1 (da)
DK (1) DK1297110T3 (da)
ES (1) ES2330411T3 (da)
WO (1) WO2002002752A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2330411T3 (es) * 2000-06-23 2009-12-10 Intervet International Bv Virus sincitial respiratorio bovino atenuado.
US7355716B2 (en) * 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
HUE032898T2 (hu) 2003-12-24 2017-11-28 De Staat Der Nederlanden Vertegenwoordigd Door De Mini Van Volksgezondheid Welzijn En Sport Légúti óriássejtes vírus transz komplementált genomi hiányossággal
DK2368975T3 (da) * 2004-12-23 2015-01-05 Medimmune Llc Ikke-tumorigen MDCK-cellelinje til opformering af vira
KR101464783B1 (ko) * 2006-09-15 2014-11-26 메디뮨 엘엘씨 높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
KR20110074564A (ko) 2008-09-24 2011-06-30 메디뮨 엘엘씨 세포 배양, 바이러스 증식 및 바이러스 정제를 위한 방법
KR20110074563A (ko) 2008-09-24 2011-06-30 메디뮨 엘엘씨 바이러스의 정제 방법
AU2009304552B2 (en) * 2008-10-16 2015-02-19 Dalhousie University Combination adjuvant formulation
AR084358A1 (es) * 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
CN105734007B (zh) * 2016-03-10 2019-06-07 金宇保灵生物药品有限公司 一种筛选对牛病毒性腹泻/黏膜病毒敏感的mdbk细胞系的方法
MX2021014912A (es) * 2019-06-07 2022-01-18 Intervet Int Bv Celula mutante mdbk con inactivacion de irf3/irf7 y su uso para producir vacunas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0702085T4 (da) * 1994-07-18 2010-04-06 Conzelmann Karl Klaus Prof Dr Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
EP0912724B1 (en) 1996-07-15 2009-12-09 The Government of The United States of America, as represented by The Department of Health and Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
US6699476B1 (en) * 1996-07-15 2004-03-02 Peter L. Collins Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
EP0974660A1 (en) 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
ES2330411T3 (es) * 2000-06-23 2009-12-10 Intervet International Bv Virus sincitial respiratorio bovino atenuado.

Also Published As

Publication number Publication date
US20050186224A1 (en) 2005-08-25
EP1297110A1 (en) 2003-04-02
ES2330411T3 (es) 2009-12-10
US7335366B2 (en) 2008-02-26
AU2001263896A1 (en) 2002-01-14
CA2412075C (en) 2011-09-20
EP1297110B1 (en) 2009-07-22
CA2412075A1 (en) 2002-01-10
DE60139319D1 (en) 2009-09-03
US6921535B2 (en) 2005-07-26
US20040037850A1 (en) 2004-02-26
WO2002002752A1 (en) 2002-01-10
ATE437223T1 (de) 2009-08-15

Similar Documents

Publication Publication Date Title
Dijkman et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63
Shimojima et al. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry
Ahmad et al. Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: an immuno-informatics approach
Weiskopf et al. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection
ATE437223T1 (de) Attenuiertes bovines respiratorisches syncytialvirus
Tian et al. Porcine gastric mucin binds to recombinant norovirus particles and competitively inhibits their binding to histo‐blood group antigens and Caco‐2 cells
ATE346160T1 (de) Proteingerüste für antikörper-mimetika und andere bindungsproteine
DE602005027258D1 (de) Humane monoklonale antikörper gegen hendra- und nipah-viren
BRPI0417023A (pt) anticorpo ou fragmento de anticorpo humanos, uso dos mesmos, composição farmacêutica, métodos para tratar um paciente que sofre de um distúrbio amilóide, para diagnosticar um distúrbio amilóide em um paciente, e para detectar a presença do apoe-ctd em uma amostra de um paciente, polinucleotìdeo, vetor, célula hospedeira, vìrus, e, kit para detectar apoe-ctd
D’Apice et al. Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay
DK0486515T3 (da) Fremgangsmåde til bestemmelse af den funktionelle aktivitet af frit protein S eller protein C i en plasmaprøve
Aabin et al. Identification of IgE-binding egg white proteins: comparison of results obtained by different methods
BR112021017603A2 (pt) Vírus adenoassociado (aav) mutante tendo propriedade de direcionamento para o cérebro
EP1090294A4 (en) METHOD FOR DETERMINING THE PRESENCE OF CANCER IN A SAMPLE BY DETECTING THE EXPRESSION OF A SSX GENE AND PEPTIDES DERIVED FROM SSX OR NY-ESO-1
CN114015725B (zh) 一种新冠病毒SARS-CoV-2完整病毒颗粒的检测方法
ATE492643T1 (de) Verbesserte adenovirusvektoren und deren verwendung
Wilson et al. Coagulation parameters following equine herpesvirus type 1 infection in horses
AR038556A1 (es) Composiciones y metodos para evaluar utilizacion del receptor/co-receptor viral e inhibidores de la entrada viral usando ensayos con virus recombinantes
Jayaraman et al. Comprehensive Enteroviral Serology Links Infection and Anti‐Melanoma Differentiation‐Associated Protein 5 Dermatomyositis
DE50200452D1 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
Schonwald Allergenic molds in the Pacific Northwest
Holmes et al. Coronavirus receptor specificity
DE60233875D1 (de) Attenuierter circovirus
Keller et al. Lack of antibody response in pigs immunized with the transmembrane envelope protein of porcine endogenous retroviruses
Kim et al. A mouse xenograft long‐term replication yields a SARS‐CoV‐2 Delta mutant with increased lethality